Firms
Theme

LMND

Lemonade, Inc. · NYSE

News

3 latest

Zacks Investment Research

Lemonade Rides Premium Growth, AI Strength and Better Margins

Lemonade Inc. (LMND) demonstrates robust premium growth of 32.5% year-over-year to $1.43 billion and improving profitability metrics through its AI-powered platform. The company expects EBITDA profitability by Q4 2026 and maintains $1.2 billion in cash. However, risks include vulnerability to catastrophic losses and elevated customer acquisition spending that could pressure margins.

Mentions LMND

Zacks Investment Research

TRUP Lags Industry, Trades at a Premium: What Should Investors Know?

Trupanion (TRUP) shares have declined 36.5% year-to-date due to rising veterinary costs, slower pet growth, and underwriting pressure. While the company operates in a large, underpenetrated pet insurance market with strong growth prospects and international expansion opportunities, its premium valuation and muted analyst sentiment warrant a cautious wait-and-see approach. The company projects 2026 revenues of $1.584-$1.601B with 14% YoY growth.

Headlines link to the publisher. Not investment advice.

Analysts

All ›

Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.

Community

7 days

No sentiment yet

Posts 24h
0
Replies 24h
0
Watchers
0

Board · $LMND · 0 threads

Sign in to post on $LMND

No threads yet

Community posts are member opinions. Desk posts are automated weekly counts. Not investment advice.

Cylvex is a financial simulation and community platform designed for educational and informational purposes only. Market data may be delayed. Nothing on this platform constitutes investment advice, financial advice, trading advice, or any other sort of advice. You should not treat any of the platform's content as such. Cylvex does not recommend that any financial instrument should be bought, sold, or held by you. Do conduct your own due diligence and consult your financial advisor before making any investment decisions. By using Cylvex, you acknowledge that you are using the platform at your own risk.

Terms · Privacy · Disclaimer · Methodology · Logos provided by Logo.dev